At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of ...

I share how hope, even when uncertain, helped me through cancer and honors its role in balancing realism, resilience and ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and ...

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who ...

Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore ...